MediBeacon® Next Generation TGFR™ System Receives FDA Approval

MediBeacon® TGFRTM System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence ...

Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the University ...